Sanofi builds $75 mn factory in Vietnam for ASEAN markets

French drugmaker Sanofi said Friday that it had begun building a new manufacturing facility in Vietnam to serve the expanding pharmaceutical market in southeast Asia.

The $75 million (58 million euro) factory "will expand Sanofi's manufacturing capacity in Vietnam to meet the fast growing demand of the Vietnamese and will serve as an export platform to ASEAN countries," the company said in a statement.

The factory in Ho Chi Minh City, Sanofi's second, is due to be completed in 2015 with an initial capacity of 90 million units per year.

also boasts factories in Indonesia, Singapore and Thailand in the 10-country Association of Southeast Asian Nations (ASEAN), a market of some 600 million people.

lgo/rl/yad

add to favorites email to friend print save as pdf

Related Stories

US solar firm to build $300 mln Vietnam plant

Jan 26, 2011

A US solar panel maker Wednesday said it will build a $300 million factory in Vietnam, boosting the country's efforts to reinvent itself as a hub for high-tech manufacturing.

Recommended for you

Lilly psoriasis drug fares well in late-stage test

2 hours ago

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

New US restrictions on painkiller to take effect

15 hours ago

The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

User comments